Using data science to detect key changes in medication intake behaviors.

Electronic monitoring, a digital technology based on smart packages, enables the most objective and precise adherence monitoring.

By using an evidence-based digital adherence monitoring system, Sponsors and HCPs improve drug efficacy by managing patient adherence to the medications.

In this Medium article (the online publishing platform), AARDEX presents the latest results from its data science and AI research team. This article highlights the new proprietary algorithms to detect and predict changes in medication intake behavior.

The integration of these algorithms in the MEMS® Adherence Software allows real-time detection of changes in medication adherence and improves the efficacy of intervention.

For over 35 years, AARDEX is the world market leader with major contributions, leading to significant advances in adherence-related sciences.

These algorithms will be available to all smart packages and smart devices compatible with the MEMS® Adherence Software.

Share This Post

You may also like...

Breaking News

Is Neglecting Medication Adherence in Neurology Drug Trials Putting Patients at Risk?

The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological

Bias in clinical Research
Breaking News

Unmasking Bias in Clinical Research: A Historical Perspective

It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,